Sanofi reported net cash proceeds of about 10 billion ($10.7 billion) from the deal, which it had outlined earlier in 2024.

Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...

Sanofi has completed the sale of a 50.0% controlling stake in its consumer healthcare division, Opella, to CD&R, creating a global leader in ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

AFRY Management Consulting has released a report titled Factors for the Siting of Biorefineries for the CSA Group, providing crucial insights int ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Indian Oil Corporation consolidated net profit rises 57.78% in the March 2025 quarter Vedanta consolidated net profit rises 154.42% in the March 2025 quarter Sanofi Consumer Healthcare India Ltdhas ...

Sanofi India Ltd., incorporated in the year 1956, is a company (having a market cap of Rs 13,744.68 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments include ...